[{"data":1,"prerenderedAt":239},["ShallowReactive",2],{"drug-etoricoxib":3},{"id":4,"schemaVersion":5,"name":6,"category":9,"class":10,"brands":13,"synonyms":17,"formulations":20,"regimens":59,"contraindications":131,"warnings":141,"renal":150,"monitoring":158,"interactions":159,"review":160,"examples":163,"atc":184,"iran":186,"links":206,"populations":216},"etoricoxib",1,{"fa":7,"en":8},"اتوریکوکسیب","Etoricoxib","musculoskeletal",{"fa":11,"en":12},"مهارکننده انتخابی COX-2","Selective COX-2 inhibitor",[14],{"name":15,"market":16},"Arcoxia","UK",[18,19,7],"arcoxia","آرکوکسیا",[21,35,43,51],{"id":22,"form":23,"route":24,"label":25,"concentration":26,"markets":30,"refs":31},"tab-30","tablet","oral","30 mg film-coated tablet",{"amount":27,"unit":28,"perUnit":23,"scored":29},30,"mg",false,[16],[32],{"source":33,"section":34},"emc-arcoxia","6.5",{"id":36,"form":23,"route":24,"label":37,"concentration":38,"markets":40,"refs":41},"tab-60","60 mg film-coated tablet",{"amount":39,"unit":28,"perUnit":23,"scored":29},60,[16],[42],{"source":33,"section":34},{"id":44,"form":23,"route":24,"label":45,"concentration":46,"markets":48,"refs":49},"tab-90","90 mg film-coated tablet",{"amount":47,"unit":28,"perUnit":23,"scored":29},90,[16],[50],{"source":33,"section":34},{"id":52,"form":23,"route":24,"label":53,"concentration":54,"markets":56,"refs":57},"tab-120","120 mg film-coated tablet",{"amount":55,"unit":28,"perUnit":23,"scored":29},120,[16],[58],{"source":33,"section":34},[60,78,92,106,118],{"id":61,"disease":62,"label":63,"population":66,"type":70,"unit":28,"dose":71,"refs":72,"limits":75},"oa","osteoarthritis",{"fa":64,"en":65},"استئوآرتریت — ۳۰ mg یک بار در روز (حداکثر ۶۰ mg)","Osteoarthritis — 30 mg once daily (max 60 mg)",{"minAge":67},{"value":68,"unit":69},16,"year","fixed",{"perDose":27,"perDoseMax":39,"dosesPerDay":5},[73],{"source":33,"section":74},"4.2",{"maxPerDay":39,"refs":76},[77],{"source":33,"section":74},{"id":79,"disease":80,"label":81,"population":84,"type":70,"unit":28,"dose":86,"refs":87,"limits":89},"ra","rheumatoid-arthritis",{"fa":82,"en":83},"آرتریت روماتوئید — ۶۰ mg یک بار در روز (حداکثر ۹۰ mg)","Rheumatoid arthritis — 60 mg once daily (max 90 mg)",{"minAge":85},{"value":68,"unit":69},{"perDose":39,"perDoseMax":47,"dosesPerDay":5},[88],{"source":33,"section":74},{"maxPerDay":47,"refs":90},[91],{"source":33,"section":74},{"id":93,"disease":94,"label":95,"population":98,"type":70,"unit":28,"dose":100,"refs":101,"limits":103},"as","ankylosing-spondylitis",{"fa":96,"en":97},"اسپوندیلیت آنکیلوزان — ۶۰ mg یک بار در روز (حداکثر ۹۰ mg)","Ankylosing spondylitis — 60 mg once daily (max 90 mg)",{"minAge":99},{"value":68,"unit":69},{"perDose":39,"perDoseMax":47,"dosesPerDay":5},[102],{"source":33,"section":74},{"maxPerDay":47,"refs":104},[105],{"source":33,"section":74},{"id":107,"disease":107,"label":108,"population":111,"type":70,"unit":28,"dose":113,"refs":114,"durationDays":116},"gout",{"fa":109,"en":110},"نقرس حاد — ۱۲۰ mg یک بار در روز، حداکثر ۸ روز","Acute gout — 120 mg once daily, max 8 days",{"minAge":112},{"value":68,"unit":69},{"perDose":55,"dosesPerDay":5},[115],{"source":33,"section":74},{"min":5,"max":117},8,{"id":119,"disease":120,"label":121,"population":124,"type":70,"unit":28,"dose":126,"refs":127,"durationDays":129},"dental","toothache",{"fa":122,"en":123},"درد پس از جراحی دندان — ۹۰ mg یک بار در روز، حداکثر ۳ روز","Pain after dental surgery — 90 mg once daily, max 3 days",{"minAge":125},{"value":68,"unit":69},{"perDose":47,"dosesPerDay":5},[128],{"source":33,"section":74},{"min":5,"max":130},3,[132],{"id":133,"severity":134,"text":135,"refs":138},"ci","block",{"fa":136,"en":137},"زخم پپتیک یا خونریزی گوارشی فعال؛ آسم، کهیر یا رینیت با آسپرین یا NSAID؛ بارداری و شیردهی؛ نارسایی شدید کبد؛ ClCr زیر ۳۰؛ زیر ۱۶ سال؛ IBD؛ نارسایی قلب NYHA II–IV؛ فشار خون کنترل‌نشده بالای ۱۴۰\u002F۹۰؛ بیماری ایسکمیک قلب، شریان محیطی یا مغزی؛ حساسیت.","Active peptic ulcer or GI bleeding; bronchospasm, rhinitis, polyps, angioedema or urticaria with aspirin\u002FNSAIDs; pregnancy and lactation; severe hepatic dysfunction; CrCl \u003C30; under 16 y; inflammatory bowel disease; NYHA II–IV heart failure; uncontrolled BP >140\u002F90; established ischaemic heart, peripheral arterial or cerebrovascular disease; hypersensitivity.",[139],{"source":33,"section":140},"4.3",[142],{"text":143,"refs":146},{"fa":144,"en":145},"خطر قلبی‌عروقی با دوز و مدت بیشتر می‌شود؛ کمترین دوز در کوتاه‌ترین مدت. عوارض گوارشی جدی.","Cardiovascular risk rises with dose and duration; lowest dose for the shortest time. Serious GI complications.",[147,148],{"source":33,"section":74},{"source":33,"section":149},"4.4",[151],{"egfrBelow":27,"severity":152,"text":153,"refs":156},"warn",{"fa":154,"en":155},"ClCr زیر ۳۰: منع مصرف.","CrCl \u003C30: contraindicated.",[157],{"source":33,"section":140},[],[],{"status":161,"reviewer":162,"date":162},"unverified",null,[164,168,173,177,181],{"regimen":61,"formulation":22,"input":165,"expect":167},{"ageYears":39,"weightKg":166},75,{"perDose":27,"tabletsPerDoseRounded":5,"upperPerDose":39},{"regimen":107,"formulation":52,"input":169,"expect":172},{"ageYears":170,"weightKg":171},50,85,{"perDose":55,"tabletsPerDoseRounded":5},{"regimen":79,"formulation":36,"input":174,"expect":176},{"ageYears":170,"weightKg":175},70,{"perDose":39,"tabletsPerDoseRounded":5},{"regimen":93,"formulation":36,"input":178,"expect":180},{"ageYears":179,"weightKg":166},35,{"perDose":39,"tabletsPerDoseRounded":5},{"regimen":119,"formulation":44,"input":182,"expect":183},{"ageYears":27,"weightKg":175},{"perDose":47,"tabletsPerDoseRounded":5},[185],"M01AH05",{"status":187,"forms":188,"refs":201},"registered",[189,193,197],{"code":190,"en":191,"fa":192},"08058","ETORICOXIB 120MG TAB","قرص اتوریکوکسیب ۱۲۰ میلی‌گرم",{"code":194,"en":195,"fa":196},"08056","ETORICOXIB 60MG TAB","قرص اتوریکوکسیب ۶۰ میلی‌گرم",{"code":198,"en":199,"fa":200},"08057","ETORICOXIB 90MG TAB","قرص اتوریکوکسیب ۹۰ میلی‌گرم",[202],{"source":203,"section":204,"url":205},"darooyab-generic","G-76\u002FEtoricoxib","https:\u002F\u002Fwww.darooyab.ir\u002FG-76\u002FEtoricoxib",[207,210,212],{"kind":208,"url":209,"label":185},"who-atc","https:\u002F\u002Fatcddd.fhi.no\u002Fatc_ddd_index\u002F?code=M01AH05",{"kind":211,"url":205,"label":8},"darooyab",{"kind":213,"url":214,"label":215},"emc","https:\u002F\u002Fwww.medicines.org.uk\u002Femc\u002Fproduct\u002F10616\u002Fsmpc","eMC Arcoxia",{"pregnancy":217,"lactation":225,"pediatric":232},{"level":218,"text":219,"quote":222,"refs":223},"contraindicated",{"fa":220,"en":221},"برچسب: در بارداری منع مصرف دارد.","Label: contraindicated in pregnancy.","… , experience bronchospasm, acute rhinitis, nasal polyps, angioneurotic oedema, urticaria, or allergic-type reactions. • Pregnancy and lactation (see sections 4.6 and 5.3). • Severe hepatic dysfunction (serum albumin \u003C 25 g\u002FL or Child-Pugh score ≥10). • Estimated renal creatinine clearance \u003C 30 mL\u002Fmin. • Children and …",[224],{"source":33,"section":140},{"level":218,"text":226,"quote":229,"refs":230},{"fa":227,"en":228},"برچسب: در شیردهی منع مصرف دارد.","Label: contraindicated while breastfeeding.","… ronchospasm, acute rhinitis, nasal polyps, angioneurotic oedema, urticaria, or allergic-type reactions. • Pregnancy and lactation (see sections 4.6 and 5.3). • Severe hepatic dysfunction (serum albumin \u003C 25 g\u002FL or Child-Pugh score ≥10). • Estimated renal creatinine clearance \u003C 30 mL\u002Fmin. • Children and adolescents …",[231],{"source":33,"section":140},{"level":218,"text":233,"quote":236,"refs":237},{"fa":234,"en":235},"برچسب: در کودکان زیر سن مشخص منع مصرف دارد.","Label: contraindicated in children below a stated age.","… tic dysfunction (serum albumin \u003C 25 g\u002FL or Child-Pugh score ≥10). • Estimated renal creatinine clearance \u003C 30 mL\u002Fmin. • Children and adolescents under 16 years of age. • Inflammatory bowel disease. • Congestive heart failure (NYHA II-IV). • Patients with hypertension whose blood pressure is persistently elevated …",[238],{"source":33,"section":140},1792156177869]